Gulf Pharmaceutical Industries operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gulf Pharmaceutical Industries with three other
pharmaceutical manufacturers in Middle East:
Astra Industrial Group
of Saudi Arabia
sales of 1.80 billion Saudi Riyals [US$478.85 million]
of which 46%
(1.65 billion Egyptian Pounds [US$93.59 million]
Kahira Pharmaceuticals and Chemical Industries Co SAE
based in Egypt
(690.18 million Egyptian Pounds [US$39.25 million]
Gulf Pharmaceutical Industries reported sales of 1.27 billion Arab Emirates Dirhams (US$346.70 million)
December of 2017.
decrease of 12.5%
versus 2016, when the company's sales were 1.45 billion Arab Emirates Dirhams.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Gulf Pharmaceutical Industries had sales
of 1.18 billion Arab Emirates Dirhams.